May 14, 2015
Baxter buys Sigma-Tau cancer drugs in $900m deal
Baxter International is shelling out $900 million on Sigma-Tau’s Oncaspar (pegaspargase) product portfolio, in a…
May 14, 2015
150th Edition – May 13, 2015
You're receiving this newsletter because of your interest in BioHealth Innovation Having trouble viewing…
May 12, 2015
NHLBI Strategic Visioning Forum – All Ideas
Welcome to the National Heart, Lung, and Blood Institute (NHLBI) Strategic Visioning Forum. The Institute…
May 12, 2015
Doubling Down On a Good Thing: The National Science Foundation’s I-Corps Lite – Steve Blank
I’ve known Edmund Pendleton from the University of Maryland as the Director of the D.C.…